阴茎海绵体内注射血管活性药物排除血管性阳萎的应用

Application of intracavenous injection of vascular dilatation drugs for excluding vasculargenic erectile dysfunction

对670例阳萎患者采用不同血管活性药物及不同剂量进行阻茎海绵体内注射（ICI）以排除血管性阳萎，结果91．5％的非血管性阳萎患者在应用罂粟碱30mg加酚妥拉明1mg后可获充分勃起，还有2.0％的患者在罂粟碱加至60mg时方获充分勃起；而对罂粟碱注射反应不佳的非血管性阳萎患者注射前列腺素E1（PGE1）25μg后，有0．9％的患者获充分勃起，当PGE1加至50μg时又有0．2％的患者获得勃起。提示不应以某种药物或单一剂量来排除血管性阳萎。

670 cases with erectile dysfunction (ED) underwent ICI to exclude vasculogenic ED. 96. 9 percent of patients with non-vasculogenic ED got full erection after ICI of Papererine 30 mg plusing Regitine 1 mg,and so did another 2 percent after adding Paperverine to 60 mg. The oth er non-vasculogenic ED patients,not responding to Paperverine,were given ICI of PGE1 25 μg,or 50 μg, another 0. 9 percent and 0. 2 percent obtained full erection respectively. These indicated that ICI of one dosage or one sort of drugs is not reliable in excluding vasculogenic ED. Persistent erection occured in 7. 8 percent of patients with ICI of Paperverine,while local pain occured in 46. 1 percent of patients with ICI of PGE1.